This is a petition to advocate against FDA approval for Flibanserin, a so-called ‘female Viagra’ recently produced by the drug company Boehringer Ingelheim. It is extremely important that the FDA does not approve Flibanserin,
This petition is written by the New View Campagin.
On their website, they say:
Please go to Change.org and look for the Low Sexual Desire petition and sign it and circulate it to others. ASAP, please. We will take these petitions to the June 18 Flibanserin hearing.
I've been following the news surrounding this drug for a while, and there is much to be troubled about. Neuroskeptic has a good post about it One pill makes your libido larger:
Flibanserin was originally developed as an antidepressant, but in clinical trials against depression it reportedly failed to perform better than placebo. The standard for getting approved as an antidepressant is low, so this is quite an achievement.
After an a review of the relevant scientific information, Neuroskeptic suggests how it works:
It's obvious from the side effects data that this drug is a sedative - it makes you tired and sleepy. The animal data confirm this. It's much more likely to put you to sleep than it is to make you enjoy sex in any given month. Off the top of my head, I suspect its sedative properties are a result of its 5HT2A antagonism.
Any sedative can increase sexual desire, as anyone who has ever been to a bar will know. So whether this drug actually has an aphrodisiac effect, as opposed to just being a sleeping pill, is anyone's guess. To find out, you'd need to compare it to a sleeping pill, say, Valium. Or a couple of glasses of wine. Until someone does that, we don't know if this drug is destined to be the next big thing or a big disappointment.
Cory Silverberg reports on the effect size:
Women taking the drug also reported more "sexually satisfying events" than women taking the placebo. The increase in satisfying events was statistically significant, but it's worth considering the actual numbers. According to the aforementioned corporate press release women taking the drug had 1.2 more satisfying sexual events over 24 weeks compared to women taking a placebo who had 0.9 more satisfying events. That's 1.2 more sexual encounters they enjoyed over a six month period.
It doesn't look like this drug is going to do much, but it seems that everyone watching knows has strong reason to believe that, if approved by the FDA, there will be massive "educational campaigns" about how oh-so-distressing a problem lack of interest in and how oh-so-widespread it is. But you begin to think that the purpose is to create distress about lack of interest in sex.
A confession: There are a number of reasons that I am opposed to Hypoactive Sexual Desire Disorder (or Sexual Interest/Arousal Disorder.) But my biggest concern is that if a drug for HSDD is ever approved, there will be massive attempts to create distress surrounding low sexual desire. Conceptually, these diagnoses make no senses, and I feel that the asexual community is in a unique position to bring to the fore these problems and to create more reasoned and more nuanced discourse surrounding low/absent sexual desire.